Innovation Research Center
Pleasanton, California, 94588, United States
NCT Number: NCT04506502
Evaluate the safety and efficacy of magnetic muscle stimulation (MMS) of abdominal muscle.
Looking for future studies?
Notify Me22 year–65 year
All sexes
Interventional
Not applicable
Pleasanton, California, 94588, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The MMS device will be used to perform the treatments.
Time frame: Baseline, 1-month post-treatment follow-up visit
Measurement of participant's perception about body shape, assessed using the Body Satisfaction Questionnaire (BSQ) at the 1-month post-treatment follow-up visit. The scale measures body image using a set of dichotomous items used to describe aspects of shape and appearance. The questionnaire has total score range from 10 to 50. An increase in score (when compared to baseline) reflects the participant's perceived improvement in appearance in the treated region (abdomen). Questionnaire results were tabulated as the numerical change between mean baseline scores and scores recorded at the 1-month post-treatment follow-up visit. A positive change reflects an increase in the body satisfaction questionnaire total score.
Time frame: AE information will be collected from the time of enrollment to the final follow-up visit at 3-months following the final treatment (approximately 4 months).
The incidence of device-related adverse events (AE) including device-related serious AEs will be tabulated.
Zeltiq Aesthetics
Industry
Functional Changes With Magnetic Muscle Stimulation of Abdominal Muscle
Acronym: FMS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05956964
Mental Disorders, Muscle Weakness
Lexington, Kentucky, United States
View Trial DetailsNCT06216015
Chronic Disease, Chronic Kidney Failure
View Trial DetailsNCT07555782
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Ataşehir, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07590557
Burn Injury, Burns
Al Kharj, Saudi Arabia
View Trial Details